Average cost of multi drug-resistant tuberculosis treatment in Syrian Arab Republic
Syrian Arab Republic: Average cost of multi drug-resistant tuberculosis treatment was 785 constant 2022 US$ in 2024. ▬ Flat
Latest (2024)
785 constant 2022 US$
Change on year
down 84.7%
World rank
63rd
of 92 countries
All-time high
5,125 constant 2022 US$
in 2023
All-time low
785 constant 2022 US$
in 2024
Years of data
8
2017–2024
Average cost of multi drug-resistant tuberculosis treatment in Syrian Arab Republic, 2017–2024
Source: WHO (2025) – with minor processing by Our World in Data. Measured in constant 2022 US$.
Analysis
Syrian Arab Republic recorded 785 constant 2022 US$ for average cost of multi drug-resistant tuberculosis treatment in 2024. That is the lowest value across all 8 years on record.
That represents a change of down 84.7% on the previous year and down 73.8% over ten years.
Syrian Arab Republic ranks 63rd of 92 countries on this measure, in the middle of the range.
Average cost of multi drug-resistant tuberculosis treatment in Syrian Arab Republic, year by year
| Year | constant 2022 US$ | Change |
|---|---|---|
| 2017 | 3,000 constant 2022 US$ | — |
| 2018 | 3,000 constant 2022 US$ | +0.0% |
| 2019 | 3,000 constant 2022 US$ | +0.0% |
| 2020 | 5,000 constant 2022 US$ | +66.7% |
| 2021 | 5,000 constant 2022 US$ | +0.0% |
| 2022 | 5,000 constant 2022 US$ | +0.0% |
| 2023 | 5,125 constant 2022 US$ | +2.5% |
| 2024 | 785 constant 2022 US$ | -84.7% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 3,000 constant 2022 US$ | 3,000 constant 2022 US$ | 3,000 constant 2022 US$ | 3 |
| 2020s | 4,182 constant 2022 US$ | 785 constant 2022 US$ | 5,125 constant 2022 US$ | 5 |
Countries ranked near Syrian Arab Republic
- 60 Republic of Moldova 824 constant 2022 US$ compare
- 61 Guatemala 813 constant 2022 US$ compare
- 62 Eritrea 793 constant 2022 US$ compare
- 64 Lao People's Democratic Republic 756 constant 2022 US$ compare
- 65 Bolivia, Plurinational State of 753 constant 2022 US$ compare
- 66 Congo 726 constant 2022 US$ compare
More health data for Syrian Arab Republic
- Un projection of annual infant deaths, annual growth rate -2.1 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.8632 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,122 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,491 deaths (2100)
- Population ages 50-54, male, annual growth rate 4.37 % change on previous year (2025)
- Population ages 50-54, male, per unit of GDP 0 units per US$ of GDP (2022)
- Population ages 50-54, male, per capita 0.02 units per person (2025)
- Population ages 55-59, female, annual growth rate 4.67 % change on previous year (2025)
- Population ages 55-59, female, per unit of GDP 0 units per US$ of GDP (2022)
- Population ages 55-59, female, per capita 0.0181 units per person (2025)
Frequently asked questions
- What is average cost of multi drug-resistant tuberculosis treatment in Syrian Arab Republic?
- Average cost of multi drug-resistant tuberculosis treatment in Syrian Arab Republic was 785 constant 2022 US$ in 2024, according to WHO (2025) – with minor processing by Our World in Data.
- What is the highest average cost of multi drug-resistant tuberculosis treatment recorded in Syrian Arab Republic?
- The highest recorded value was 5,125 constant 2022 US$ in 2023.
- What is the lowest average cost of multi drug-resistant tuberculosis treatment recorded in Syrian Arab Republic?
- The lowest recorded value was 785 constant 2022 US$ in 2024.
- How does Syrian Arab Republic rank for average cost of multi drug-resistant tuberculosis treatment?
- Syrian Arab Republic ranks 63rd out of 92 countries with data for 2024.
- Is average cost of multi drug-resistant tuberculosis treatment rising or falling in Syrian Arab Republic?
- Over the last ten years it is down 73.8%. The long-run trend across the full record is flat.
- Where does this Syrian Arab Republic data come from?
- The figures come from WHO (2025) – with minor processing by Our World in Data, published as part of Average cost of multi drug-resistant tuberculosis treatment. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 8 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Average cost of drugs spent per patient starting multidrug-resistant tuberculosis treatment, excluding buffer stock.